GeoVax Labs, Inc. (GOVX)
0.5068
-0.05
(-8.27%)
USD |
NASDAQ |
Sep 03, 16:00
0.5067
0.00 (0.00%)
After-Hours: 06:10
GeoVax Labs Enterprise Value : 0.9144M for Sept. 3, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 0.9144M |
| September 02, 2026 | 1.251M |
| September 01, 2026 | 1.642M |
| August 31, 2026 | 1.84M |
| August 28, 2026 | 2.493M |
| August 27, 2026 | 2.463M |
| August 26, 2026 | 1.823M |
| August 25, 2026 | 1.91M |
| August 24, 2026 | 2.237M |
| August 21, 2026 | 1.937M |
| August 20, 2026 | 1.616M |
| August 19, 2026 | 1.562M |
| August 18, 2026 | 1.973M |
| August 17, 2026 | 2.006M |
| August 14, 2026 | 2.471M |
| August 13, 2026 | 2.469M |
| August 12, 2026 | 2.527M |
| August 11, 2026 | 2.854M |
| August 10, 2026 | 2.736M |
| August 07, 2026 | 2.853M |
| August 06, 2026 | 2.494M |
| August 05, 2026 | 2.646M |
| August 04, 2026 | 2.795M |
| August 03, 2026 | 2.520M |
| July 31, 2026 | 2.200M |
| Date | Value |
|---|---|
| July 30, 2026 | 2.357M |
| July 29, 2026 | 2.325M |
| July 28, 2026 | 2.535M |
| July 27, 2026 | 2.780M |
| July 24, 2026 | 2.568M |
| July 23, 2026 | 3.370M |
| July 22, 2026 | 4.077M |
| July 21, 2026 | 4.512M |
| July 20, 2026 | 4.438M |
| July 17, 2026 | 4.359M |
| July 16, 2026 | 3.594M |
| July 15, 2026 | 4.623M |
| July 14, 2026 | 4.917M |
| July 13, 2026 | 5.360M |
| July 10, 2026 | 5.875M |
| July 09, 2026 | 5.802M |
| July 08, 2026 | 5.728M |
| July 07, 2026 | 5.949M |
| July 06, 2026 | 6.391M |
| July 02, 2026 | 5.949M |
| July 01, 2026 | 6.465M |
| June 30, 2026 | 6.539M |
| June 29, 2026 | 2.731M |
| June 26, 2026 | 2.843M |
| June 25, 2026 | 2.815M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 615.81M |
| Amgen, Inc. | 283.41B |
| Anika Therapeutics, Inc. | 267.88M |
| BioCryst Pharmaceuticals, Inc. | 3.059B |
| Imunon, Inc. | 8.259M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.427M |
| Total Expenses (Quarterly) | 4.427M |
| EPS Diluted (Quarterly) | -0.9696 |
| Earnings Yield | -2.75K% |
| Normalized Earnings Yield | -2748.15 |